Simba Gill - Insider Monkey
Simba Gill
Source: insidermonkey.com
📰 Simba Gill News
Simba Gill News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Simba Gill. Real-time updates on events, politics, business and more.
Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights
14.08.2023 - – EDP2939 Phase 2 trial in moderate psoriasis fully enrolled with topline data expected early Q4 2023– Completed $25.5 Million Private Placement– Restructured and reduced secured debt with Horizon Technology Finance Corporation CAMBRIDGE, Mass., ...
Evelo Biosciences Evelo Biosciences Inc Horizon Technology Finance Corporation Development Rd Expenses Simba Gill Chief Executive Officer
Source: wallstreet-online.de
Evelo Biosciences Provides Clinical Updates
– Topline Data from fourth cohort of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint –– Company will focus on development of extracellular vesicles ... | April 26, 2023
United States United Kingdom Evelo Biosciences Evelo Biosciences Inc Exchange Commission Topline Data
Source: marketscreener.com
Evelo Biosciences, Inc. (NASDAQ:EVLO) Q4 2022 Earnings Call Transcript
Operator: Good morning and welcome to the Evelo Biosciences Conference Call to discuss its Fourth Quarter and Full Year 2022 Financial Results and Business Update.
Source: insidermonkey.com
Evelo Biosciences, Inc. (EVLO) Q2 2022 Earnings Call Transcript
EVLO earnings call for the period ending June 30, 2022.
Evelo Biosciences Chris Howerton Jefferies Kristen Kluska Chris Howerton Kristen Kluska Cantor Fitzgerald Joe Thome Cowen
Source: fool.com
CORRECTION: Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights
12.05.2022 - CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) - In a release issued under the same headline on Thursday, May 12 by Evelo Biosciences, Inc. (Nasdaq: EVLO), please note that in the first sentence of the First Quarter 2022 Financial Results ...
Source: wallstreet-online.de
Evelo Biosciences Appoints John Maraganore, Ph.D. and Tassos Gianakakos as Strategic Advisors
CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that John Maraganore,
Source: kulr8.com
Evelo Biosciences Appoints John Maraganore, Ph.D. and Tassos Gianakakos as Strategic Advisors
Evelo Biosciences Appoints John Maraganore, Ph.D. and Tassos Gianakakos as Strategic Advisors - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com
Evelo Biosciences, Inc. (EVLO) Q4 2021 Earnings Call Transcript
EVLO earnings call for the period ending December 31, 2021.
Source: fool.com
Evelo Biosciences, Inc. (EVLO) Q3 2021 Earnings Call Transcript
EVLO earnings call for the period ending September 30, 2021.
United Kingdom Evelo Biosciences Chris Howerton Jefferies Keay Nakae Alex Zaboronok Keay Nakae Chardan
Source: fool.com